Skip to main content

Table 2 The relationship between clinical factors and risk scores or the expression of seven prognostic related immune genes in hepatocellular carcinoma

From: A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma

ID (t/P)

Age

Gender

Grade

Stage

T

M

N

Futime

1.613 (0.110)

0.772 (0.442)

0.59 (0.556)

2.533 (0.012)

2.572 (0.011)

1.716 (0.212)

0.661 (0.570)

FABP6

0.727 (0.469)

−0.295 (0.768)

−1.975 (0.050)

− 1.163 (0.247)

− 1.23 (0.222)

− 0.363 (0.750)

2.93 (0.017)

MAPT

0.599 (0.550)

1.337 (0.184)

0.556 (0.579)

−1.101 (0.273)

−1.373 (0.173)

0.935 (0.439)

11.791 (4.946e-14)

BIRC5

−1.645 (0.102)

0.294 (0.769)

−3.054 (0.003)

−2.601 (0.011)

−2.563 (0.012)

2.133 (0.124)

−1.121 (0.374)

PLXNA1

−0.668 (0.506)

2.563 (0.012)

−2.456 (0.015)

−2.198 (0.030)

−1.61 (0.110)

1.044 (0.400)

−3.213 (0.082)

CSPG5

−0.632 (0.529)

−0.448 (0.655)

−1.902 (0.059)

−1.288 (0.201)

− 1.383 (0.170)

2.511 (0.055)

0.868 (0.466)

SPP1

0.514 (0.608)

−1.584 (0.116)

−1.325 (0.187)

−2.061 (0.042)

− 1.843 (0.068)

−0.535 (0.646)

−0.174 (0.878)

STC2

1.179 (0.242)

0.715 (0.476)

−1.356 (0.177)

−1.599 (0.113)

− 1.504 (0.136)

−0.943 (0.444)

−0.177 (0.875)

Risk Score

−0.09 (0.929)

−0.146 (0.884)

−3.027 (0.003)

−2.955 (0.004)

−2.819 (0.006)

− 0.362 (0.750)

− 1.56 (0.226)

  1. Note: t t value of student’s t test, P: P-value of student’s t test